Skip to main content
Fig. 9 | BMC Genomics

Fig. 9

From: Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients

Fig. 9

Predictive values of DR score in immunotherapy response. A TIDE, dysfunction, exclusion scores of two risk groups. B CD274 (PD1) levels calculated by the TIDE algorithm of two risk groups. C MDSC, CAF, and TAM. M2 scores of two risk groups. D MSI expression signature of two risk groups. E Distribution of responders and no-responders predicted by the TIDE algorithm bewteen two risk groups in the TCGA cohort. F Distribution of DR score between responders and no-responders predicted by the TIDE algorithm in the TCGA cohort. G Distribution of responders and no-responders between two risk groups in the Braun cohort (CheckMate). H Distribution of DR score between responders and no-responders between two risk groups in the Braun cohort (CheckMate). I Correlation analysis of the TIDE score and DR score. J Prediction of the response to anti-PD1 and anti-CTLA4 inhibitors in two risk groups by the submap algorithm. *P < 0.05, **P < 0.01, ***P < 0.001, ns: no significance

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us